US 10851358
Engineered meganucleases specific for recognition sequences in the hepatitis B virus genome
granted A61KA61K38/00A61K38/43
Quick answer
US patent 10851358 (Engineered meganucleases specific for recognition sequences in the hepatitis B virus genome) held by Precision BioSciences, Inc. expires Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Precision BioSciences, Inc.
- Grant date
- Tue Dec 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K38/00, A61K38/43, A61K9/51, A61P